{"sourcedb":"DevicePMAs@therightstef","sourceid":"P980018_S010","text":"Approval for the herceptest kit.  The device is indicated for in vitro diagnostic use.  Herceptest is a semi-quantitative immunocytochemi-cal assay to determine her2 protein overexpression in breast cancer tissues routinely processed for histological evaluation and formalin-fixed, paraffin-embedded cancer tissue from patients with metastatic gastric or gastroesophageal junction adenocarcinoma.  Herceptest is indicated as an aid in the assessment of patients for whom herceptin (trastuzumab) treatment is being considered (see herceptin package insert).","project":"consensus_PMA_Age_Indications"}